| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
2 companies
Ho Carole is a Chief Medical Officer at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 37 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2020 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 3,689 | $31.00 | $114,359.00 | -2.2% | |
| Mar 30, 2020 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 1,428 | $19.48 | $27,817.44 | -33.6% | |
| Dec 23, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 6,890 | $20.01 | $137,834.64 | -46.9% | |
| Jul 8, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 17,500 | $20.29 | $355,011.26 | -9.4% | |
| Jun 10, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 17,500 | $18.78 | $328,653.42 | -16.1% | |
| May 10, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 17,500 | $22.85 | $399,901.38 | -3.9% | |
| Apr 4, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 9,588 | $26.35 | $252,678.20 | -4.0% | |
| Apr 3, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 36,805 | $25.44 | $936,284.81 | -8.8% | |
| Mar 14, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 1,000 | $25.01 | $25,010.00 | -0.7% | |
| Mar 5, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 17,500 | $22.17 | $388,000.33 | -83.1% |